F1000Research peer-reviewed articles now visible on PubMed and PubMed Central

December 12, 2013

Since its launch at the start of this year, F1000Research has published over 300 articles, and continues to challenge the traditional scholarly publishing model through its innovative, open and transparent Open Science publishing model. Today F1000Research announce that its first articles are now visible in PubMed and PMC, and from now, new articles will be deposited with these indexers as soon as they pass peer review.

All articles accepted by F1000Research are published rapidly (on average, articles are published live on the site within seven days of acceptance) using an open access license, and are then formally peer reviewed by invited referees. Referee comments and names are published with the original article. This process aims to remove the standard publication delays and significantly reduce referee and publication bias.

The Open Science publishing model has afforded new opportunities to capture and index a wider range of associated rich article metadata. F1000Research publish referee reports, author responses and underlying data alongside the article itself, and has worked with the National Library of Medicine (NLM) to ensure this additional information is accessible in PMC by developing a more robust way of archiving full-text biomedical literature. This marks a milestone in the communication of scientific findings, and one that will help to lead the way for the increasing number of other publishers who are now developing similar approaches to publication.

Commenting on the visibility of F1000Research articles in PubMed and PMC, Rebecca Lawrence, Managing Director of F1000Research, said: "We would like to extend our thanks to all our existing authors for their patience while we worked through the complexities of these issues with NLM. We are extremely grateful for the support of these early adopters of our publishing approach, without whom our achievements thus far wouldn't have been possible."
-end-
To find out more about F1000Research, please contact Eleanor Howell on +44 (0)20 7631 9129 or email press@f1000.com. For more information on open science publishing, visit F1000Research.com/about">http://F1000Research.com/about.

Example quotes from F1000Research Authors

"The submission and publication process can only be described as exhilarating. To see a paper in 5 days in a professional layout after dealing with courteous and efficient staff is quite astounding. Two useful referee reports appeared in less than 2 weeks supporting the notion that peer review can be done openly."

Jürgen Schnermann, Chief of the Kidney Disease Branch at NIDDK/NIH

"After my article was published, the open post publication peer review process was extremely quick! My article received two reviews in the space of just 5 days, which is a refreshing change from the traditional reviewing system. I believe this type of review system will become a new standard for scientific publications in the near future."

Hajime Takizawa, University of Tokyo, Japan

"Publishing in F1000Research enabled complete open access of my work; both the analysis and the data can be easily re-used and redistributed by the wider science community, whilst being fully attributed to me."

Manuel Corpas, Genome Analysis Centre, Norwich, UK

About F1000Research

F1000Research is an original open science journal for life scientists that offers rapid open access publication, transparent peer review (post-publication) and full data deposition and sharing. The journal accepts all scientifically sound articles, including single findings, case reports, protocols, replications, null/negative results and more traditional articles. F1000Research is published by U.K.-based Faculty of 1000 (F1000) and has offices in London and New York.

Faculty of 1000

Related Additional Information Articles from Brightsurf:

Patients at risk of atrial fibrillation may need additional monitoring after heart surgery
There appears to be a high rate of unrecognized atrial fibrillation in the month following heart surgery among people who have an increased risk of stroke, even when atrial fibrillation was not detected immediately following surgery.

Study provides additional support for use of new class of diabetes drugs
A new study led by a cardiologist from Brigham and Women's Hospital has assessed the cardiovascular and renal outcomes for ertugliflozin, an SGLT2 inhibitor prescribed for patients with type 2 diabetes to help them control blood sugar levels.

0.5°C of additional warming has a huge effect on global aridity
In a simulation study, UTokyo researchers showed that limiting global warming to 1.5°C rather than 2°C will mitigate aridification in some regions of the world including the Mediterranean, western Europe, and southern Africa.

COVID-19 patients with sleep apnoea could be at additional risk
People who have been diagnosed with obstructive sleep apnoea could be at increased risk of adverse outcomes from COVID-19 according to a new study from the University of Warwick.

Additional data on blood thinner efficacy for COVID-19 and insight on best possible regimens
Mount Sinai study is the basis of a new international clinical trial.

Doctors motivated by both health, malpractice concerns when ordering additional tests
A UCLA-led study has found that dermatopathologists, who specialize in diagnosing skin diseases at the microscopic level, are motivated both by patient safety concerns and by malpractice fears -- often simultaneously -- when ordering multiple tests and obtaining second opinions, with a higher proportion of these doctors reporting patient safety as a concern.

Additional genetic cause for non-alcoholic fatty liver disease discovered
Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease in Europe and the United States.

HPV vaccine hesitancy in Japan could result in 5,000 additional death
The precipitous drop in HPV vaccination rates after suspension of proactive recommendations by the government in 2013 could result in an additional 25,000 cervical cancer cases and more than 5,000 additional deaths among females born between 1994 to 2007 in Japan.

Study shows risks for additional procedures after bariatric surgery
Which of the two most common bariatric surgeries -- gastric sleeve or gastric bypass -- has the highest subsequent risk of additional operations or procedures?

An additional component can triple vaccine efficiency, and scientists explained how
A team of Russian scientists carried out a study on the cell immunity level and found out how an adjuvant called azoximer bromide increases the immunogenicity of the anti-flu vaccine.

Read More: Additional Information News and Additional Information Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.